相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Minireview: Basal-Like Breast Cancer: From Molecular Profiles to Targeted Therapies
Daniel J. Toft et al.
MOLECULAR ENDOCRINOLOGY (2011)
Wnt/β-Catenin Pathway Activation Is Enriched in Basal-Like Breast Cancers and Predicts Poor Outcome
Andrey I. Khramtsov et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
The proteins FABP7 and OATP2 are associated with the basal phenotype and patient outcome in human breast cancer
H. Zhang et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Subtypes of familial breast tumours revealed by expression and copy number profiling
Nic Waddell et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
CD44 is overexpressed in basal-like breast cancers but is not a driver of 11p13 amplification
Pamela Klingbeil et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Synthetic Lethality through Combined Notch-Epidermal Growth Factor Receptor Pathway Inhibition in Basal-Like Breast Cancer
Yiyu Dong et al.
CANCER RESEARCH (2010)
FOXC1 Is a Potential Prognostic Biomarker with Functional Significance in Basal-like Breast Cancer
Partha S. Ray et al.
CANCER RESEARCH (2010)
Breast cancer precursors revisited: molecular features and progression pathways
Maria A. Lopez-Garcia et al.
HISTOPATHOLOGY (2010)
Clinicopathological features and treatment strategy for triple-negative breast cancer
Yutaka Yamamoto et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2010)
Androgen receptor in breast cancer: expression in estrogen receptor-positive tumors and in estrogen receptor-negative tumors with apocrine differentiation
Leo A. Niemeier et al.
MODERN PATHOLOGY (2010)
Genomic instability in breast cancer: Pathogenesis and clinical implications
Kevin A. Kwei et al.
MOLECULAR ONCOLOGY (2010)
Overexpression of fatty acid binding protein-7 correlates with basal-like subtype of breast cancer
Xiao Yan Tang et al.
PATHOLOGY RESEARCH AND PRACTICE (2010)
Invasive ductal carcinoma of the breast with the triple-negative phenotype: prognostic implications of EGFR immunoreactivity
Giuseppe Viale et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Overexpression of E2F-5 correlates with a pathological basal phenotype and a worse clinical outcome
S. Umemura et al.
BRITISH JOURNAL OF CANCER (2009)
Global Histone Modifications in Breast Cancer Correlate with Tumor Phenotypes, Prognostic Factors, and Patient Outcome
Somaia E. Elsheikh et al.
CANCER RESEARCH (2009)
Characterization of a Naturally Occurring Breast Cancer Subset Enriched in Epithelial-to-Mesenchymal Transition and Stem Cell Characteristics
Bryan T. Hennessy et al.
CANCER RESEARCH (2009)
The Complex Relationship between BRCA1 and ERα in Hereditary Breast Cancer
Julia J. Gorski et al.
CLINICAL CANCER RESEARCH (2009)
Triple-Negative Breast Cancer: Distinguishing between Basal and Nonbasal Subtypes
Emad A. Rakha et al.
CLINICAL CANCER RESEARCH (2009)
IMP3 is a novel biomarker for triple negative invasive mammary carcinoma associated with a more aggressive phenotype
Otto Walter et al.
HUMAN PATHOLOGY (2009)
Discovery of a 2,4-Diamino-7-aminoalkoxyquinazoline as a Potent and Selective Inhibitor of Histone Lysine Methyltransferase G9a
Feng Liu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers.
Peter C. Fong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
CD146 expression is associated with a poor prognosis in human breast tumors and with enhanced motility in breast cancer cell lines
Gwladys Zabouo et al.
BREAST CANCER RESEARCH (2009)
αB-crystallin:: A novel marker of invasive basal-like and metaplastic breast carcinomas
Stephanie M. Sitterding et al.
ANNALS OF DIAGNOSTIC PATHOLOGY (2008)
Caveolin 1 and caveolin 2 are associated with breast cancer basal-like and triple-negative immunophenotype
S. E. Elsheikh et al.
BRITISH JOURNAL OF CANCER (2008)
Analysis of integrin β4 expression in human breast cancer:: Association with basal-like tumors and prognostic significance
Shaolei Lu et al.
CLINICAL CANCER RESEARCH (2008)
Triple-Negative Breast Cancer: Risk Factors to Potential Targets
Bryan P. Schneider et al.
CLINICAL CANCER RESEARCH (2008)
What is triple-negative breast cancer?
William J. Irvin et al.
EUROPEAN JOURNAL OF CANCER (2008)
Basal cytokeratin expression in relation to biological factors in breast cancer
Hajime Kuroda et al.
HUMAN PATHOLOGY (2008)
Basal-like breast cancer: A critical review
Emad A. Rakha et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Nestin is expressed in basal-like and triple negative breast cancers
S. Parry et al.
JOURNAL OF CLINICAL PATHOLOGY (2008)
Impact of basal-like breast carcinoma determination for a more specific therapy
Ernad A. Rakha et al.
PATHOBIOLOGY (2008)
CD109 expression in basal-like breast carcinoma
Masaki Hasegawa et al.
PATHOLOGY INTERNATIONAL (2008)
Sustained induction of epithelial to mesenchymal transition activates DNA methylation of genes silenced in basal-like breast cancers
Nancy Dumont et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Basal-like subtype of breast cancer: a review of its unique characteristics and their clinical significance
Shunzo Kobayashi
BREAST CANCER (2008)
Epidemiology of basal-like breast cancer
Robert C. Millikan et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Distribution and significance of caveolin 2 expression in normal breast and invasive breast cancer: an immunofluorescence and immunohistochemical analysis
Kay Savage et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
The functional loss of the retinoblastoma tumour suppressor is a common event in basal-like and luminal B breast carcinomas
Jason I. Herschkowitz et al.
BREAST CANCER RESEARCH (2008)
Integrated profiling of basal and luminal breast cancers
Jose Adelaide et al.
CANCER RESEARCH (2007)
Moesin expression is a marker of basal breast carcinomas
Emmanuelle Charafe-Jauffret et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Vimentin and laminin expression is associated with basal-like phenotype in both sporadic and BRCA1-associated breast carcinomas
Socorro Maria Rodriguez-Pinilla et al.
JOURNAL OF CLINICAL PATHOLOGY (2007)
Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers
Sendurai A. Mani et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Nestin is expressed in the basal/myoepithelial layer of the mammary gland and is a selective marker of basal epithelial breast tumors
Hua Li et al.
CANCER RESEARCH (2007)
Prognostic markers in triple-negative breast cancer
Emad A. Rakha et al.
CANCER (2007)
Caveolin 1 is overexpressed and amplified in a subset of basal-like and metaplastic breast carcinomas: A morphologic, ultrastructural, immunohistochemical, and in situ hybridization analysis
Kay Savage et al.
CLINICAL CANCER RESEARCH (2007)
P-cadherin and cytokeratin 5: useful adjunct markers to distinguish basal-like ductal carcinomas in situ
Joana Paredes et al.
VIRCHOWS ARCHIV (2007)
Deconstructing the molecular portrait of basal-like breast cancer
Fruma Yehiely et al.
TRENDS IN MOLECULAR MEDICINE (2006)
Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer
Anna Bergamaschi et al.
GENES CHROMOSOMES & CANCER (2006)
Caveolin-1 expression is associated with a basal-like phenotype in sporadic and hereditary breast cancer
Socorro Maria Rodriguez Pinilla et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
DNA hypermethylation in breast cancer and its association with clinicopathological features
ShaoYing Li et al.
CANCER LETTERS (2006)
Prognostic significance of basal-like phenotype and fascin expression in node-negative invasive breast carcinomas
SM Rodríguez-Pinilla et al.
CLINICAL CANCER RESEARCH (2006)
Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation
EA Rakha et al.
JOURNAL OF PATHOLOGY (2006)
Distribution and significance of nerve growth factor receptor (NGFR/p75NTR) in normal, benign and malignant breast tissue
JS Reis et al.
MODERN PATHOLOGY (2006)
alpha B-crystallin is a novel oncoprotein that predicts poor clinical outcome in breast cancer
JV Moyano et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Wnt signaling pathway in mammary gland development and carcinogenesis
Gulisa Turashvili et al.
PATHOBIOLOGY (2006)
p63 correlates with both BRCA1 and cytokeratin 5 in invasive breast carcinomas: further evidence for the pathogenesis of the basal phenotype of breast cancer
A Ribeiro-Silva et al.
HISTOPATHOLOGY (2005)
p63, cytokeratin 5, and P-cadherin: three molecular markers to distinguish basal phenotype in breast carcinomas
I Matos et al.
VIRCHOWS ARCHIV (2005)
Identification of molecular apocrine breast tumours by microarray analysis
P Farmer et al.
ONCOGENE (2005)
Hypermethylation in histologically distinct classes of breast cancer
YK Bae et al.
CLINICAL CANCER RESEARCH (2004)
Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma
TO Nielsen et al.
CLINICAL CANCER RESEARCH (2004)
Nonrandom distribution of aberrant promoter methylation of cancer-related genes in sporadic breast tumors
P Parrella et al.
CLINICAL CANCER RESEARCH (2004)
Molecular portraits of breast cancer: tumour subtypes as distinct disease entities
T Sorlie
EUROPEAN JOURNAL OF CANCER (2004)
Loss of heterozygosity and its correlation with expression profiles in subclasses of invasive breast cancers
ZGC Wang et al.
CANCER RESEARCH (2004)
Repeated observation of breast tumor subtypes in independent gene expression data sets
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Molecular classification of familial non-BRCA1/BRCA2 breast cancer
I Hedenfalk et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Cytogenetic alterations and cytokeratin expression patterns in breast cancer: Integrating a new model of breast differentiation into cytogenetic pathways of breast carcinogenesis
E Korsching et al.
LABORATORY INVESTIGATION (2002)
Gene expression profiling predicts clinical outcome of breast cancer
LJ van't Veer et al.
NATURE (2002)
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)